MedPath

Inventprise, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:2
Completed:1

Trial Phases

2 Phases

Phase 1:2
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (50.0%)
Phase 2
2 (50.0%)

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Phase 2
Active, not recruiting
Conditions
Pneumococcal Disease, Invasive
Interventions
Biological: Formulation B
Biological: Formulation C
First Posted Date
2025-01-24
Last Posted Date
2025-04-16
Lead Sponsor
Inventprise Inc.
Target Recruit Count
421
Registration Number
NCT06790290
Locations
🇵🇭

Health Index Multispecialty Clinic, Bacoor, Cavite, Philippines

🇵🇭

Grand Centennial Homes Clinic, Kawit, Cavite, Philippines

🇵🇭

University of the Philippines-National Health Institute_Doña Nena Health Center, Pasay, Metro Manila, Philippines

Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.

Phase 1
Recruiting
Conditions
Group B Streptococcal Infections
Interventions
Biological: IVT GBS-06
Biological: Placebo
First Posted Date
2024-09-24
Last Posted Date
2025-01-17
Lead Sponsor
Inventprise Inc.
Target Recruit Count
600
Registration Number
NCT06611371
Locations
🇺🇸

NYU Grossman School of Medicine, New York, New York, United States

🇿🇦

Wits Vaccines and Infectious Diseases Analytics Research Unit (Wits-VIDA), University of the Witwatersrand, Johannesburg, Gauteng, South Africa

Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine

Phase 2
Active, not recruiting
Conditions
Pneumococcal Vaccines
First Posted Date
2023-10-11
Last Posted Date
2023-12-13
Lead Sponsor
Inventprise Inc.
Target Recruit Count
220
Registration Number
NCT06077656
Locations
🇨🇦

Inventprise Clinical Site, Saint Louis, Quebec, Canada

Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine

Phase 1
Completed
Conditions
Pneumococcal Vaccines
First Posted Date
2022-09-14
Last Posted Date
2023-08-30
Lead Sponsor
Inventprise Inc.
Target Recruit Count
65
Registration Number
NCT05540028
Locations
🇨🇦

Canadian Center for Vaccinology, IWK Health Centre, Halifax, Nova Scotia, Canada

News

No news found
© Copyright 2025. All Rights Reserved by MedPath